159 related articles for article (PubMed ID: 8179967)
1. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands.
Benson J; Tschachler E; Gessain A; Yanagihara R; Gallo RC; Franchini G
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):91-6. PubMed ID: 8179967
[TBL] [Abstract][Full Text] [Related]
2. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I.
Hoshino H; Nakamura T; Tanaka Y; Miyoshi I; Yanagihara R
J Infect Dis; 1993 Dec; 168(6):1368-73. PubMed ID: 7504032
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868
[TBL] [Abstract][Full Text] [Related]
4. Molecular phylogeny and dissemination of human T-cell lymphotropic virus type I viewed within the context of primate evolution and human migration.
Yanagihara R; Saitou N; Nerurkar VR; Song KJ; Bastian I; Franchini G; Gajdusek DC
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S145-61. PubMed ID: 8574142
[TBL] [Abstract][Full Text] [Related]
5. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.
Gessian A; Yanagihara R; Franchini G; Garruto RM; Jenkins CL; Ajdukiewicz AB; Gallo RC; Gajdusek DC
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7694-8. PubMed ID: 1881912
[TBL] [Abstract][Full Text] [Related]
6. Genetic and phylogenetic analyses of human T-cell lymphotropic virus type I variants from Melanesians with and without spastic myelopathy.
Nerurkar VR; Song KJ; Melland RR; Yanagihara R
Mol Neurobiol; 1994; 8(2-3):155-73. PubMed ID: 7999313
[TBL] [Abstract][Full Text] [Related]
7. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
[TBL] [Abstract][Full Text] [Related]
8. Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I.
Blanchard S; Astier-Gin T; Moynet D; Edouard E; Guillemain B
Virology; 1998 May; 245(1):90-8. PubMed ID: 9614870
[TBL] [Abstract][Full Text] [Related]
9. Interfamilial and intrafamilial genomic diversity and molecular phylogeny of human T-cell lymphotropic virus type I from Papua New Guinea and the Solomon Islands.
Nerurkar VR; Song KJ; Saitou N; Melland RR; Yanagihara R
Virology; 1993 Oct; 196(2):506-13. PubMed ID: 8372432
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis against a Melanesian variant of human T-lymphotropic virus type I (HTLV-I) in rabbits using HTLV-I immune globulin from asymptomatically infected Japanese carriers.
Tanaka Y; Ishii K; Sawada T; Ohtsuki Y; Hoshino H; Yanagihara R; Miyoshi I
Blood; 1993 Dec; 82(12):3664-7. PubMed ID: 8260703
[TBL] [Abstract][Full Text] [Related]
11. A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia.
Cassar O; Charavay F; Touzain F; Jeannin P; Grangeon JP; Laumond S; Chungue E; Martin PM; Gessain A
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005278. PubMed ID: 28060812
[TBL] [Abstract][Full Text] [Related]
12. Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor.
Cassar O; Capuano C; Bassot S; Charavay F; Duprez R; Afonso PV; Abel M; Walter H; Mera W; Martin PM; Chungue E; Gessain A
J Infect Dis; 2007 Aug; 196(4):510-21. PubMed ID: 17624835
[TBL] [Abstract][Full Text] [Related]
13. Genotyping of human T cell lymphotropic virus type I using Australo-Melanesian topotype-specific oligonucleotide primer-based polymerase chain reaction: insights into viral evolution and dissemination.
Nerurkar VR; Song KJ; Bastian IB; Garin B; Franchini G; Yanagihara R
J Infect Dis; 1994 Dec; 170(6):1353-60. PubMed ID: 7995973
[TBL] [Abstract][Full Text] [Related]
14. Failure to isolate human T cell lymphotropic virus type I and to detect variant-specific genomic sequences by polymerase chain reaction in Melanesians with indeterminate western immunoblot.
Nerurkar VR; Miller MA; Leon-Monzon ME; Ajdukiewicz AB; Jenkins CL; Sanders RC; Godec MS; Garruto RM; Yanagihara R
J Gen Virol; 1992 Jul; 73 ( Pt 7)():1805-10. PubMed ID: 1629703
[TBL] [Abstract][Full Text] [Related]
15. Primate T-lymphotropic virus type I LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-I.
Vandamme AM; Liu HF; Goubau P; Desmyter J
Virology; 1994 Jul; 202(1):212-23. PubMed ID: 8009833
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states.
Astier-Gin T; Portail JP; Londos-Gagliardi D; Moynet D; Blanchard S; Dalibart R; Pouliquen JF; Georges-Courbot MC; Hajjar C; Sainte-Foie S; Guillemain B
J Infect Dis; 1997 Mar; 175(3):716-9. PubMed ID: 9041352
[TBL] [Abstract][Full Text] [Related]
17. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians.
Lal RB; Rudolph DL; Nerurkar VR; Yanagihara R
Viral Immunol; 1992; 5(4):265-72. PubMed ID: 1282011
[TBL] [Abstract][Full Text] [Related]
18. Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I.
Gessain A; Mahieux R; de Thé G
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S132-45. PubMed ID: 8797716
[TBL] [Abstract][Full Text] [Related]
19. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
20. Detection of neutralizing antibodies against human T-cell leukemia virus type 1 using a cell-free infection system and polymerase chain reaction.
Haraguchi Y; Yang DW; Handa A; Shimizu N; Tanaka Y; Hoshino H
Int J Cancer; 1994 Nov; 59(3):416-21. PubMed ID: 7927951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
